On going Goblet next arm The announced formalization of next goblet arm & the strong wording from the various project oversight people, is good news.
It shows on - going commitment & trust in Pelareorep.
The FOLFIRINOX, co- therapy arm, could be interesting?
I do not belive it is held by any individual pharma , as it is if itself a combination of 4 various treatments.
Folirinox is also highly toxic , as are many chemo drugs & combinations.
So that aspect could be concerning.
We have heard mutiple times Pela is safe & well tolerated. Some mimic that statement. Yet! Is very important.
I know cancer & I know chemo. In some situations, the treatment is more damaging than the cancer.
The hard part is killing only cancer cells.
Pela only replicates in cancer cells.
Yes today is good news. As s continued endorsement to oncolytics biotech & Pela.
What is missing is the all important $$$ piece of the puzzle.
Another potential use for Pela is great. They do however need $ to moving into phase 3.
partneship, buyout or other.
I dont think Thursday will be anything groundbreaking.
However , they need answers, either before ( tomorrow'), or very soon after.
The analysts will be giving updated projections based on what they know to be true & expectations of future income & various times.
With Onc anything is possible.
stay tuned